SE9402157L - Framaceutisk komposition med analgetisk aktivitet - Google Patents

Framaceutisk komposition med analgetisk aktivitet

Info

Publication number
SE9402157L
SE9402157L SE9402157A SE9402157A SE9402157L SE 9402157 L SE9402157 L SE 9402157L SE 9402157 A SE9402157 A SE 9402157A SE 9402157 A SE9402157 A SE 9402157A SE 9402157 L SE9402157 L SE 9402157L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
analgesic activity
ibuprofen
arginine
mixture
Prior art date
Application number
SE9402157A
Other languages
English (en)
Swedish (sv)
Other versions
SE9402157D0 (sv
Inventor
Federico Stroppolo
Daniele Bonadeo
Gian Franco Fornasini
Annibale Gazzaniga
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of SE9402157D0 publication Critical patent/SE9402157D0/xx
Publication of SE9402157L publication Critical patent/SE9402157L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SE9402157A 1993-06-21 1994-06-20 Framaceutisk komposition med analgetisk aktivitet SE9402157L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001325A IT1264856B1 (it) 1993-06-21 1993-06-21 Composizione farmaceutica ad attivita' analgesica

Publications (2)

Publication Number Publication Date
SE9402157D0 SE9402157D0 (sv) 1994-06-20
SE9402157L true SE9402157L (sv) 1994-12-22

Family

ID=11366436

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402157A SE9402157L (sv) 1993-06-21 1994-06-20 Framaceutisk komposition med analgetisk aktivitet

Country Status (15)

Country Link
US (2) US5500226A (xx)
JP (1) JPH07101855A (xx)
BE (1) BE1007194A3 (xx)
CA (1) CA2125643C (xx)
CH (1) CH687850A5 (xx)
DE (1) DE4420856A1 (xx)
DK (1) DK174687B1 (xx)
ES (1) ES2099021B1 (xx)
FR (1) FR2706892B1 (xx)
GB (1) GB2279250B (xx)
HU (1) HU211669A9 (xx)
IT (1) IT1264856B1 (xx)
NL (1) NL193820C (xx)
NO (1) NO310443B1 (xx)
SE (1) SE9402157L (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
US5707967A (en) * 1995-10-27 1998-01-13 Vanmoor; Arthur Pain relief compositions
CA2266098A1 (en) * 1996-09-26 1998-04-02 Oklahoma Medical Research Foundation Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression
AU3221599A (en) 1998-04-03 1999-10-25 Daily Wellness Company, The Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
AU2002258013A1 (en) * 2001-04-10 2002-10-28 Fakhreddin Jamali Animal model for evaluating analgesics
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
KR100678837B1 (ko) 2005-01-03 2007-02-05 한미약품 주식회사 활성 성분으로 덱시부프로펜을 함유하는 시럽제 조성물 및그의 제조 방법
KR100730393B1 (ko) 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
MX2010004974A (es) * 2010-05-04 2011-11-23 Senosiain S A De C V Lab Combinacion de un aine y un aminoacido.
KR101890649B1 (ko) * 2013-07-30 2018-09-28 라이온 가부시키가이샤 정제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
DE3639038C2 (de) * 1986-11-14 1997-02-06 Helmut Dr Lukas Verwendung von S-(+)-Ibuprofen zur schnellen Behandlung humaner Schmerzen
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
DE69022678T2 (de) * 1989-10-17 1996-03-21 Merck & Co Inc S(+)-Ibuprofen-L-Aminosäure und S(+)-Ibuprofen-D-Aminosäure als Analgetika mit grösserem pharmakologischem Potential.
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica

Also Published As

Publication number Publication date
BE1007194A3 (fr) 1995-04-18
NO942343D0 (xx) 1994-06-20
CA2125643C (en) 2007-09-04
HU211669A9 (en) 1995-12-28
NO310443B1 (no) 2001-07-09
CA2125643A1 (en) 1994-12-22
DE4420856A1 (de) 1994-12-22
SE9402157D0 (sv) 1994-06-20
CH687850A5 (it) 1997-03-14
GB2279250B (en) 1998-02-25
ITMI931325A0 (it) 1993-06-21
FR2706892B1 (xx) 1995-10-20
NL9401005A (nl) 1995-01-16
NO942343L (no) 1994-12-22
ITMI931325A1 (it) 1994-12-21
JPH07101855A (ja) 1995-04-18
NL193820C (nl) 2000-12-04
US5500226A (en) 1996-03-19
US5645857A (en) 1997-07-08
DK72594A (da) 1994-12-22
NL193820B (nl) 2000-08-01
DK174687B1 (da) 2003-09-15
GB2279250A (en) 1995-01-04
ES2099021B1 (es) 1998-01-16
GB9410898D0 (en) 1994-07-20
FR2706892A1 (xx) 1994-12-30
IT1264856B1 (it) 1996-10-17
ES2099021A1 (es) 1997-05-01

Similar Documents

Publication Publication Date Title
SE9402157D0 (sv) Framaceutisk komposition med analgetisk aktivitet
IE862404L (en) Hydroxamic acid derivatives
ES2099022A1 (es) Composiciones farmaceuticas que contienen las sales de acido s(+)-2-(4-isobutilfenil) propionico con aminoacidos basicos.
IT8619004A0 (it) Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
AU633217B2 (en) Oral composition
ATE225647T1 (de) Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
ATE210983T1 (de) Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
AU5993590A (en) Pharmaceutical composition for oral administration containing n-acetyl-cysteine and trihydroxy methylamino methane
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
ATE60713T1 (de) Pharmazeutische zusammensetzung aus guar-gummi und anderen antiacida zum schutz der oeso-gastro- duodenalen schleimhaut.
DK481388D0 (da) Calciumtilskud
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
ITMI930582A1 (it) Composizione farmeceutiche ad attivita' analgesica
ATE192435T1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
EP0356945A3 (de) Verwendung von Plasminogen-Aktivator-Inhibitor (PAI-2) zur Immunsuppression
MY101821A (en) Quinazolinediones and pyridopyrimidinediones
MY111755A (en) Use of 4'-iodo-4'- deoxydoxorubicin for the treatment of amyloidosis.
GR3001613T3 (en) A "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) for use in therapy by topical application
ZA893274B (en) Pharmaceutical composition containing a combination of analgesic agents
TW360538B (en) Pharmaceutical composition containing 4'-iodo-4'-deoxydoxorubicin for treatment of amyloidosis
BR9609937A (pt) Composição contendo ácido mefenâmico em associação com codeìna

Legal Events

Date Code Title Description
NAV Patent application has lapsed